A new method for determination of both thalidomide enantiomers using HPLC systems

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 3, 2008, Pages 497-500

  Sembongi, Kaname ^a,b   Tanaka, Masanori ^a   Sakurada, Keisuke ^a   Kobayashi, Masaki ^b   Itagaki, Shirou ^b   Hirano, Takeshi ^b   Iseki, Ken ^b  

^a Japan Post   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Enantiomer; Multiple myeloma; Simultaneous separation; Thalidomide

Indexed keywords

ACETONITRILE; ACETYLSALICYLIC ACID; ALLOPURINOL; AZULENE DERIVATIVE; BENIDIPINE; BROTIZOLAM; CITRIC ACID; DIGOXIN; ETIZOLAM; FLUNITRAZEPAM; FUROSEMIDE; GLIMEPIRIDE; LANSOPRAZOLE; LOXOPROFEN; MECOBALAMIN; METHANOL; PILSICAINIDE; PREDNISOLONE; RISEDRONIC ACID; TERBINAFINE; THALIDOMIDE; TRICHLOROACETIC ACID; VALSARTAN;

ADULT; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; ENANTIOMER; FEMALE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MULTIPLE MYELOMA; QUANTITATIVE ANALYSIS; SPECTRAL SENSITIVITY;

ANGIOGENESIS INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MOLECULAR STRUCTURE; MULTIPLE MYELOMA; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; THALIDOMIDE;

EID: 41149093399     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.497     Document Type: Article

References (27)

1. McBride W. G., Lancet, 2, 1358 (1961).
2. Lenz W., Lancet, 1, 45 (1962).
3. Koch H. P., Prog. Med. Chem., 22, 166-242 (1985).
4. Gardner-Medwin J. M., Exp. Opin. Invest. Drug, 5, 829-841 (1996).
5. D'Amato R. J., Loughnan M. S., Flynn E., Folkman J., Proc. Natl. Acad. Sci. U.S.A., 91, 4082-4085 (1994).
6. Marwick C., J. Am. Med. Assoc., 278, 1135-1137 (1997).
7. Kaplan G., Moreira A. L., Res. Immunol., 145, 685-689 (1994).
8. Barnhill R. L., Mc Dougall A. C., J. Am. Dermatol., 7, 317-323 (1982).
9. Stirling D., Annu. Rep. Med. Chem., 30, 319-327 (1995).
10. Ochonsky J. S., Revuz J., Eur. J. Dermatol., 3, 9-15 (1994).
11. Vacca A., Ribatti D., Roncali L., Ranieri G., Serio G., Silvestris F., Dammacco F., Br. J. Haematol., 87, 503-508 (1994).
12. Eriksson T., Bjorkman S., Fyge A., Ekberg H., J. Chromatogr., 582, 211-216 (1992).
13. Czejka M. J., Koch H. P., J. Chromatogr., 413, 181-187 (1987).
14. Chen T. L., Vogelsang G. B., Petty B. G., Brundrett R. B., Noe D. A., Santos G. W., Colvin O. M., Drug Metab. Dispos., 17, 402-405 (1989).
15. Toraño J. S., Verbon A., Guchelaar H. J., J. Chromatogr. B, 734, 203-210 (1999).
16. Teo S. K., Colburn W. A., Thomas S. D., J. Clin. Pharmacol., 39, 1162-1168 (1999).
17. Yang X., Hu Z., Chan S. Y., Ho P. C., Chan E., Duan W., Goh B. C., Zhou S., J. Pharm. Biomed. Anal., 39, 299-304 (2005).
18. Schumacher H., Smith R. L., Williams R. T., Br. J. Pharmacol. Chemother., 25, 324-337 (1965).
19. Murphy-Poulton S. F., Boyle F., Gu X. Q., Mather L. E., J. Chromatogr. B, 831, 48-56 (2006).
20. Eriksson T., Björkman S., Clin. Chem., 43, 1094-1096 (1997).
21. Meyring M., Chankvetadze B., Blaschke G., J. Chromatogr. A, 876, 157-167 (2000).
22. Zhang Y., Watts W., Nogle L., McConnell O., J. Chromatogr. A, 1049, 75-84 (2004).
23. Eriksson T., Björkman S., Roth B., Fyge A., Höglund P., Chirality, 10, 223-228 (1998).
24. Eriksson T., Björkman S., Roth B., Höglund P., J. Pharm. Pharmacol., 52, 807-817 (2000).
25. Duval R., Lévêque H., Prigent Y., Aboul-Enein H. Y., Biomed. Chromatogr., 15, 202-206 (2001).
26. Knoche B., Blaschke G., J. Chromatogr., 666, 235-240 (1994).
27. Reepmeyer J. C., Chirality, 8, 11-17 (1996).